Sources | Names Used |
---|---|
CTRPv2 | decitabine:carboplatin (1:1 mol/mol) |
PharmacoGx | decitabine:carboplatin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | IFNA2 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.003 |
mRNA | PTPRCAP | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | DAXX | CTRPv2 | pan-cancer | AAC | 0.087 | 0.003 |
mRNA | RUNX3 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.003 |
mRNA | AC090154.1 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.003 |
mRNA | SRPX | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
mRNA | EIF5AL1 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.003 |
mRNA | WDR19 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.003 |
mRNA | TMEM239 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.003 |
mRNA | TDG | CTRPv2 | pan-cancer | AAC | 0.088 | 0.003 |